迪哲医药(688192.SH)发布前三季度业绩，归母净亏损5.8亿元

Core Viewpoint - Dige Medical (688192.SH) reported significant revenue growth in the first three quarters of 2025, but also faced substantial net losses [1] Financial Performance - The company achieved a revenue of 586 million yuan in the first three quarters, representing a year-on-year growth of 73.23% [1] - The net loss attributable to shareholders was 580 million yuan [1] - The non-recurring net profit loss was 631 million yuan [1] - The basic earnings per share were -1.32 yuan [1]